Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

被引:24
|
作者
Lande, Asgeir [1 ,2 ,3 ]
Fluge, Oystein [4 ,5 ]
Strand, Elin B. [6 ,7 ]
Flam, Siri T. [1 ,2 ]
Sosa, Daysi D. [8 ]
Mella, Olav [4 ,5 ]
Egeland, Torstein [3 ,9 ]
Saugstad, Ola D. [10 ]
Lie, Benedicte A. [1 ,2 ,3 ,9 ]
Viken, Marte K. [1 ,2 ,9 ]
机构
[1] Univ Oslo, Dept Med Genet, Oslo, Norway
[2] Oslo Univ Hosp, Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Oslo, Norway
[4] Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway
[5] Univ Bergen, Dept Clin Sci, Bergen, Norway
[6] Oslo Univ Hosp, Natl Advisory Unit CFS ME, Oslo, Norway
[7] VID Specialized Univ, Fac Hlth Sci, Stavanger, Norway
[8] Oslo Univ Hosp, CFS ME Ctr, Oslo, Norway
[9] Oslo Univ Hosp, Dept Immunol, Oslo, Norway
[10] Univ Oslo, Oslo Univ Hosp, Dept Pediat Res, Oslo, Norway
关键词
HLA; DISEASE; DISEQUILIBRIUM; AUTOANTIBODIES; MECHANISMS; REGION;
D O I
10.1038/s41598-020-62157-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The etiology and pathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are unknown, and autoimmunity is one of many proposed underlying mechanisms. Human Leukocyte Antigen (HLA) associations are hallmarks of autoimmune disease, and have not been thoroughly investigated in a large ME/CFS patient cohort. We performed high resolution HLA -A, -B, -C, -DRB1, -DQB1 and -DPB1 genotyping by next generation sequencing in 426 adult, Norwegian ME/CFS patients, diagnosed according to the Canadian Consensus Criteria. HLA associations were assessed by comparing to 4511 healthy and ethnically matched controls. Clinical information was collected through questionnaires completed by patients or relatives. We discovered two independent HLA associations, tagged by the alleles HLA-C*07:04 (OR 2.1 [95% CI 1.4-3.1]) and HLA-DQB1*03:03 (OR 1.5 [95% CI 1.1-2.0]). These alleles were carried by 7.7% and 12.7% of ME/CFS patients, respectively. The proportion of individuals carrying one or both of these alleles was 19.2% in the patient group and 12.2% in the control group (OR 1.7 [95% CI 1.3-2.2], p(nc) = 0.00003). ME/CFS is a complex disease, potentially with a substantial heterogeneity. We report novel HLA associations pointing toward the involvement of the immune system in ME/CFS pathogenesis.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
    Booth, Norman E.
    Myhill, Sarah
    McLaren-Howard, John
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 5 (03): : 208 - 220
  • [2] Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A preliminary survey among patients in Switzerland
    Tschopp, Rea
    Konig, Rahel S.
    Rejmer, Protazy
    Paris, Daniel H.
    HELIYON, 2023, 9 (05)
  • [3] Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) in Adolescents: Practical Guidance and Management Challenges
    Rowe, Katherine
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2023, 14 : 13 - 26
  • [4] Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine
    Magnus, Per
    Gunnes, Nina
    Tveito, Kari
    Bakken, Inger Johanne
    Ghaderi, Sara
    Stoltenberg, Camilla
    Hornig, Mady
    Lipkin, W. Ian
    Trogstad, Lill
    Haberg, Siri E.
    VACCINE, 2015, 33 (46) : 6173 - 6177
  • [5] KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial
    Montoya, Jose G.
    Anderson, Jill N.
    Adolphs, Danya L.
    Bateman, Lucinda
    Klimas, Nancy
    Levine, Susan M.
    Garvert, Donn W.
    Kaiser, Jon D.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2890 - 2900
  • [6] Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME)
    Lupo, Giuseppe Francesco Damiano
    Rocchetti, Gabriele
    Lucini, Luigi
    Lorusso, Lorenzo
    Manara, Elena
    Bertelli, Matteo
    Puglisi, Edoardo
    Capelli, Enrica
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
    Lidbury, Brett A.
    Kita, Badia
    Lewis, Donald P.
    Hayward, Susan
    Ludlow, Helen
    Hedger, Mark P.
    de Kretser, David M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [8] Hypothalamus volumes in adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): impact of self-reported fatigue and illness duration
    Byrne, Hollie
    Josev, Elisha K.
    Knight, Sarah J.
    Scheinberg, Adam
    Rowe, Katherine
    Lubitz, Lionel
    Seal, Marc L.
    BRAIN STRUCTURE & FUNCTION, 2023, 228 (07) : 1741 - 1754
  • [9] Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey
    Vyas, Jui
    Muirhead, Nina
    Singh, Ravinder
    Ephgrave, Rachel
    Finlay, Andrew Y.
    BMJ OPEN, 2022, 12 (05):
  • [10] Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis
    Proal, Amy D.
    Albert, Paul J.
    Marshall, Trevor G.
    Blaney, Greg P.
    Lindseth, Inge A.
    IMMUNOLOGIC RESEARCH, 2013, 56 (2-3) : 398 - 412